Page last updated: 2024-10-23

azathioprine and Genetic Predisposition

azathioprine has been researched along with Genetic Predisposition in 55 studies

Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.

Research Excerpts

ExcerptRelevanceReference
"An 11-year-old girl with a calpain-3 gene (CAPN-3) mutation and eosinophilic myositis on muscle biopsy had high serum CK levels and eosinophil counts which showed spontaneous fluctuations."7.75Eosinophilic myositis in calpainopathy: could immunosuppression of the eosinophilic myositis alter the early natural course of the dystrophic disease? ( Dincer, P; Gundesli, H; Oflazer, PS; Sabuncu, T; Zorludemir, S, 2009)
"Azathioprine (AZA) is a thiopurine prodrug which is widely used in patients with inflammatory bowel disease (IBD)."5.42The impact of glutathione S-transferase genotype and phenotype on the adverse drug reactions to azathioprine in patients with inflammatory bowel diseases. ( Bi, H; Ding, L; Gao, X; Hu, P; Huang, M; Liu, H; Zhang, F; Zhang, Y, 2015)
"Our work supports the strong evidence that individuals with TPMT variant homozygosity are at high risk of severe neutropenia, whereas TPMT heterozygotes are not at increased risk of ADRs at standard doses of azathioprine."5.15A pragmatic randomized controlled trial of thiopurine methyltransferase genotyping prior to azathioprine treatment: the TARGET study. ( Alder, JE; Andrews, J; Bruce, I; Elles, R; Elliott, RA; Fargher, E; Griffiths, CE; Heise, M; Houston, JB; Newman, WG; Ollier, WE; Payne, D; Payne, K; Pushpakom, S; Qasim, F; Ramsden, SC; Ray, DW; Roberts, SA; Shaffer, J; Sidgwick, GP; Tricker, K, 2011)
" The thiopurine drugs, azathioprine and 6-mercaptopurine, are commonly used to maintain remission in Crohn's disease and ulcerative colitis; however, the use of these drugs may be limited by the development of pancreatitis in some individuals."4.91Thiopurine-induced pancreatitis in inflammatory bowel diseases. ( Day, AS; Ledder, O; Lemberg, DA, 2015)
"Pancreatitis occurs in approximately 4% of patients treated with the thiopurines azathioprine or mercaptopurine."3.80HLA-DQA1-HLA-DRB1 variants confer susceptibility to pancreatitis induced by thiopurine immunosuppressants. ( Ahmad, T; Andrews, JM; Annese, V; Bampton, P; Barnardo, M; Bell, S; Bewshea, CM; Chen, M; Cole, A; Connor, SJ; Creed, T; Cummings, FR; D'Amato, M; Daneshmend, TK; Dubois, PC; Fedorak, RN; Florin, TH; Gaya, DR; Greig, E; Halfvarson, J; Hart, A; Heap, GA; Holden, AL; Irving, PM; Jones, G; Karban, A; Lawrance, IC; Lee, JC; Lees, C; Lev-Tzion, R; Lindsay, JO; Mansfield, J; Mawdsley, J; Mazhar, Z; Orchard, TR; Parkes, M; Parnell, K; Radford-Smith, G; Reffitt, D; Rossjohn, J; Russell, RK; Satchwell, JB; Satsangi, J; Silverberg, MS; Singh, A; So, K; Sturniolo, GC; Tremelling, M; Tsianos, EV; van Heel, DA; Vivian, JP; Walsh, A; Watermeyer, G; Weedon, MN; Weersma, RK; Zeissig, S, 2014)
"An 11-year-old girl with a calpain-3 gene (CAPN-3) mutation and eosinophilic myositis on muscle biopsy had high serum CK levels and eosinophil counts which showed spontaneous fluctuations."3.75Eosinophilic myositis in calpainopathy: could immunosuppression of the eosinophilic myositis alter the early natural course of the dystrophic disease? ( Dincer, P; Gundesli, H; Oflazer, PS; Sabuncu, T; Zorludemir, S, 2009)
"Our results confirm that TPMT genotyping prior to the treatment with azathioprine could predict patients with genetic predisposition for serious leucopenia and seems to be a useful genetic marker for individualisation of the therapy."3.75Importance of thiopurine S-Methyltransferase gene polymorphisms for prediction of azathioprine toxicity. ( Bartos, M; Bartosova, L; Batovsky, M; Chylkova, A; Dvorackova, D; Hosek, J; Kolorz, M; Zboril, V, 2009)
"Of all azathioprine treated patients, 11 experienced an adverse event for which azathioprine was stopped: pancreatitis (n = 4), leucopenia (n = 2) and 'general malaise' (n = 5)."3.73Pharmacogenetics of thiopurine therapy in paediatric IBD patients. ( Benninga, MA; De Ridder, L; Escher, JC; Hommes, DW; Stokkers, PC; Van der Woude, JC; Van Deventer, HJ; Van Dieren, JM; Van Vuuren, AJ, 2006)
"Azathioprine, off-label used long time ago to treat multiple sclerosis (MS) patients, has recently received approval from the Spanish Medicine Agency (Agencia Española del Medicamento) in relapsing-remitting (RR) forms of this condition."3.71[Hypomethylation and multiple sclerosis, the susceptibility factor?]. ( Cara Terribas, CJ; González Guijarro, L, 2002)
"The International Autoimmune Hepatitis Group (IAIHG) has devised diagnostic scoring systems to help in comparative studies and clinical practice."2.53Cutting edge issues in autoimmune hepatitis. ( Krawitt, EL; Liberal, R; Manns, MP; Mieli-Vergani, G; Vergani, D; Vierling, JM, 2016)
"Autoimmune hepatitis is a chronic inflammatory disease of the liver with a dismal prognosis when left untreated."2.46Autoimmune hepatitis. ( Strassburg, CP, 2010)
"Pediatric ulcerative colitis tends to present with more severe and more extensive involvement than in adults."2.44IBD in children: lessons for adults. ( Haller, CA; Markowitz, J, 2007)
"Autoimmune hepatitis has a global distribution and affects all ages."2.41Current concepts in the diagnosis, pathogenesis, and treatment of autoimmune hepatitis. ( Al-Khalidi, JA; Czaja, AJ, 2001)
" NUDT15 variants are associated with thiopurine-induced adverse events, particularly in Asians."1.56Rare Genotype of His/His in NUDT15 Codon 139 and Thiopurine-associated Adverse Events in a Case of Ulcerative Colitis. ( Kakuta, Y; Kawata, Y; Okamoto, D; Sato, H; Terai, S; Tominaga, K; Tomiyoshi, K; Yokoyama, J, 2020)
"The included patients had either Crohn's disease (54; 65."1.51Long-term effect of NUDT15 R139C on hematologic indices in inflammatory bowel disease patients treated with thiopurine. ( Akiyama, S; Arai, M; Fujii, T; Fukuda, K; Hamada, S; Hashiguchi, M; Hisamatsu, T; Iwao, Y; Kanai, T; Kiyohara, H; Matsuoka, K; Mizuno, S; Mochizuki, M; Motobayashi, M; Nagahori, M; Naganuma, M; Nanki, K; Ogata, H; Ohtsuka, K; Saito, E; Shimizu, M; Sugimoto, S; Suzuki, K; Takenaka, K; Watanabe, M, 2019)
"Despite NUDT15 variants showing significant association with thiopurine-induced adverse events (AEs) in Asians, it remains unclear which variants of NUDT15 or whether additional genetic variants should be tested to predict AEs."1.48NUDT15 codon 139 is the best pharmacogenetic marker for predicting thiopurine-induced severe adverse events in Japanese patients with inflammatory bowel disease: a multicenter study. ( Andoh, A; Araki, H; Endo, K; Hanai, H; Hiraoka, S; Hisamatsu, T; Hokari, R; Ikeya, K; Ishiguro, Y; Kakuta, Y; Kawai, Y; Kinouchi, Y; Kobayashi, T; Masamune, A; Matsumoto, T; Miura, M; Mizuno, S; Moroi, R; Motoya, S; Naganuma, M; Nagasaki, M; Naito, T; Nakagawa, S; Nakagawa, T; Nakamura, S; Nakase, H; Nishida, A; Okamoto, D; Onodera, K; Sakuraba, H; Sasaki, M; Shiga, H; Shimosegawa, T; Shinozaki, M; Suzuki, Y; Takagawa, T; Takahara, M; Toyonaga, T; Yanai, S, 2018)
" The median dosage for NUDT15 c."1.46Combined Detection of NUDT15 Variants Could Highly Predict Thiopurine-induced Leukopenia in Chinese Patients with Inflammatory Bowel Disease: A Multicenter Analysis. ( Cao, Q; Chao, K; Gao, X; Hu, P; Huang, M; Huang, Y; Huang, Z; Lan, P; Liang, J; Lin, L; Qian, J; Sun, Y; Wang, X; Wu, K; Xue, X; Yang, H; Zhang, Y; Zhu, X, 2017)
"Thiopurine-induced severe hair loss causes cosmetic problems, and it takes a long time to recover."1.43NUDT15 R139C causes thiopurine-induced early severe hair loss and leukopenia in Japanese patients with IBD. ( Endo, K; Kakuta, Y; Kimura, T; Kinouchi, Y; Kuroha, M; Naito, T; Negoro, K; Onodera, M; Shiga, H; Shimosegawa, T, 2016)
" The aim of the study was to investigate frequencies of TPMT and ITPA polymorphisms in Lithuanian IBD patients and analyze their association with AZA-related adverse events."1.43TPMT and ITPA genetic variants in Lithuanian inflammatory bowel disease patients: Prevalence and azathioprine-related side effects. ( Denapiene, G; Jonaitis, L; Kiudelis, G; Kupcinskas, J; Kupcinskas, L; Skieceviciene, J; Steponaitiene, R; Survilaite, S; Valantinas, J; Varkalaite, G, 2016)
"Thiopurine-induced leukopenia is a relatively common adverse event related to thiopurine medication in Korean pediatric Crohn's disease."1.43NUDT15 variant is the most common variant associated with thiopurine-induced early leukopenia and alopecia in Korean pediatric patients with Crohn's disease. ( Hwang, EH; Kang, B; Kim, SY; Lee, YJ; Park, JH; Shin, JH, 2016)
"Azathioprine (AZA) is a thiopurine prodrug which is widely used in patients with inflammatory bowel disease (IBD)."1.42The impact of glutathione S-transferase genotype and phenotype on the adverse drug reactions to azathioprine in patients with inflammatory bowel diseases. ( Bi, H; Ding, L; Gao, X; Hu, P; Huang, M; Liu, H; Zhang, F; Zhang, Y, 2015)
"A total of 174 patients with ulcerative colitis, 99 women and 75 men, were included."1.40IL23R polymorphisms influence phenotype and response to therapy in patients with ulcerative colitis. ( Brito, M; Correia, LA; Cravo, ML; de Deus, JR; Ferreira, PA; Maio, RF; Ministro, P; Moura-Santos, P; Peixe, P; Sousa, P; Tavares, L; Velho, S; Velosa, JF, 2014)
"Crohn's disease is rare in South African black people and primary sclerosing cholangitis (PSC) is also rare in black patients with IBD, from South Africa."1.38Primary sclerosing cholangitis, Crohn's disease and HLA-B27 in black South African women. ( Bezuidenhout, E; Bosch, FJ; Buchel, OC; de K Grundling, H; de Vries, CS; Fevery, J; Janse van Rensburg, J; Middlecote, BD; van Zyl, JH, 2012)
"Azathioprine is an immunosuppressant prescribed for the treatment of inflammatory conditions and after organ transplantation."1.34Current use of pharmacogenetic testing: a national survey of thiopurine methyltransferase testing prior to azathioprine prescription. ( Bruce, I; Elliott, R; Fargher, EA; Newman, W; Payne, K; Roberts, SA; Shaffer, JL; Tricker, K, 2007)
"Genetic susceptibility to type 1 autoimmune hepatitis is indicated by a preponderance of female subjects and strong associations with human leukocyte antigens (HLA) DRB1*0301 and DRB1*0401."1.31Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms and susceptibility to type 1 autoimmune hepatitis. ( Agarwal, K; Czaja, AJ; Donaldson, PT; Jones, DE, 2000)

Research

Studies (55)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's23 (41.82)29.6817
2010's29 (52.73)24.3611
2020's3 (5.45)2.80

Authors

AuthorsStudies
Yang, J2
Wang, P1
Qin, Z1
Jia, M1
Zhang, C1
Tian, X1
Zheng, Y1
Zhang, A1
Zhang, X1
Liu, S1
Tomiyoshi, K1
Sato, H1
Tominaga, K1
Kawata, Y1
Okamoto, D2
Kakuta, Y3
Yokoyama, J1
Terai, S1
Moreno Moraleda, I1
Lázaro Sáez, M1
Diéguez Castillo, C1
Hernández Martínez, Á1
Sakaguchi, H2
Mizuochi, T1
Haruta, M1
Takase, R1
Yoshida, S1
Yamashita, Y1
Nishikomori, R1
Chao, K1
Wang, X1
Cao, Q1
Qian, J1
Wu, K1
Zhu, X1
Yang, H1
Liang, J1
Lin, L1
Huang, Z1
Zhang, Y2
Huang, Y1
Sun, Y1
Xue, X1
Huang, M2
Hu, P2
Lan, P1
Gao, X2
Adalı, G1
Ersoy Tunalı, N1
Yorulmaz, E1
Tiryakioğlu, NO1
Mungan, SG1
Ulaşoğlu, C1
Yılmaz Enç, F1
Tuncer, İ1
Yang, X1
Xu, H1
Yang, L1
Kawai, Y1
Takagawa, T1
Ikeya, K1
Sakuraba, H1
Nishida, A1
Nakagawa, S1
Miura, M1
Toyonaga, T1
Onodera, K1
Shinozaki, M1
Ishiguro, Y1
Mizuno, S2
Takahara, M1
Yanai, S1
Hokari, R1
Nakagawa, T1
Araki, H1
Motoya, S1
Naito, T2
Moroi, R1
Shiga, H2
Endo, K2
Kobayashi, T1
Naganuma, M2
Hiraoka, S1
Matsumoto, T1
Nakamura, S1
Nakase, H1
Hisamatsu, T2
Sasaki, M1
Hanai, H1
Andoh, A1
Nagasaki, M1
Kinouchi, Y2
Shimosegawa, T2
Masamune, A1
Suzuki, Y1
Weidinger, S1
Beck, LA1
Bieber, T1
Kabashima, K1
Irvine, AD1
Akiyama, S1
Matsuoka, K1
Fukuda, K1
Hamada, S1
Shimizu, M1
Nanki, K1
Kiyohara, H1
Arai, M1
Sugimoto, S1
Iwao, Y1
Ogata, H1
Motobayashi, M1
Suzuki, K1
Takenaka, K1
Fujii, T1
Saito, E1
Nagahori, M1
Ohtsuka, K1
Mochizuki, M1
Watanabe, M1
Hashiguchi, M1
Kanai, T1
Buchel, OC1
Bosch, FJ1
Janse van Rensburg, J1
Bezuidenhout, E1
de Vries, CS1
van Zyl, JH1
Middlecote, BD1
de K Grundling, H1
Fevery, J1
Cravo, ML1
Ferreira, PA1
Sousa, P1
Moura-Santos, P1
Velho, S1
Tavares, L1
de Deus, JR1
Ministro, P1
Peixe, P1
Correia, LA1
Velosa, JF1
Maio, RF1
Brito, M1
Galatola, M1
Miele, E1
Strisciuglio, C1
Paparo, L1
Rega, D1
Delrio, P1
Duraturo, F1
Martinelli, M1
Rossi, GB1
Staiano, A1
Izzo, P1
De Rosa, M1
Heap, GA1
Weedon, MN1
Bewshea, CM1
Singh, A1
Chen, M1
Satchwell, JB1
Vivian, JP1
So, K1
Dubois, PC1
Andrews, JM1
Annese, V1
Bampton, P1
Barnardo, M1
Bell, S1
Cole, A1
Connor, SJ1
Creed, T1
Cummings, FR1
D'Amato, M1
Daneshmend, TK1
Fedorak, RN1
Florin, TH2
Gaya, DR1
Greig, E1
Halfvarson, J1
Hart, A1
Irving, PM1
Jones, G1
Karban, A2
Lawrance, IC1
Lee, JC1
Lees, C2
Lev-Tzion, R1
Lindsay, JO1
Mansfield, J1
Mawdsley, J1
Mazhar, Z1
Parkes, M1
Parnell, K1
Orchard, TR1
Radford-Smith, G1
Russell, RK1
Reffitt, D1
Satsangi, J2
Silverberg, MS1
Sturniolo, GC1
Tremelling, M1
Tsianos, EV1
van Heel, DA1
Walsh, A1
Watermeyer, G1
Weersma, RK1
Zeissig, S1
Rossjohn, J1
Holden, AL1
Ahmad, T1
Ledder, O1
Lemberg, DA1
Day, AS1
Onodera, M1
Kuroha, M1
Kimura, T1
Negoro, K1
Liu, H1
Ding, L1
Zhang, F1
Bi, H1
Steponaitiene, R1
Kupcinskas, J1
Survilaite, S1
Varkalaite, G1
Jonaitis, L1
Kiudelis, G1
Denapiene, G1
Valantinas, J1
Skieceviciene, J1
Kupcinskas, L1
Lee, YJ1
Hwang, EH1
Park, JH1
Shin, JH1
Kang, B1
Kim, SY1
Liberal, R1
Krawitt, EL1
Vierling, JM1
Manns, MP1
Mieli-Vergani, G1
Vergani, D1
Yamamoto-Furusho, JK1
Kaser, A1
Tilg, H1
Oflazer, PS1
Gundesli, H1
Zorludemir, S1
Sabuncu, T1
Dincer, P1
Takatsu, N1
Matsui, T1
Murakami, Y1
Ishihara, H1
Hisabe, T1
Nagahama, T1
Maki, S1
Beppu, T1
Takaki, Y1
Hirai, F1
Yao, K1
Weiss, B1
Lebowitz, O1
Fidder, HH1
Maza, I1
Levine, A1
Shaoul, R1
Reif, S1
Bujanover, Y1
Kolorz, M2
Bartosova, L2
Hosek, J1
Dvorackova, D1
Chylkova, A1
Zboril, V2
Batovsky, M2
Bartos, M2
Jolobe, O1
Nagy, ZB1
Csanád, M1
Tóth, K1
Börzsönyi, B1
Demendi, C1
Rigó, J1
Joó, JG1
Strassburg, CP2
Ernst, A1
Andersen, V1
Ostergaard, M1
Jacobsen, BA1
Pedersen, IS1
Drewes, AM1
Okkels, H1
Krarup, HB1
Newman, WG1
Payne, K2
Tricker, K2
Roberts, SA2
Fargher, E1
Pushpakom, S1
Alder, JE1
Sidgwick, GP1
Payne, D1
Elliott, RA1
Heise, M1
Elles, R1
Ramsden, SC1
Andrews, J1
Houston, JB1
Qasim, F1
Shaffer, J1
Griffiths, CE1
Ray, DW1
Bruce, I2
Ollier, WE1
Büning, C1
Geissler, N1
Prager, M1
Sturm, A1
Baumgart, DC1
Büttner, J1
Bühner, S1
Haas, V1
Lochs, H1
Murakami, M1
Shimane, K1
Takahashi, H1
Tomiyama, J1
Nagashima, M1
Vajro, P1
Paolella, G1
Wroblova, K1
Suchankova, J1
Ulicny, B1
Pav, I1
Roberts, RL1
Barclay, ML1
Pender, MP1
Wolfe, NP1
Ho, GT1
Merk, HF1
Allorge, D1
Hamdan, R1
Broly, F1
Libersa, C1
Colombel, JF1
De Ridder, L1
Van Dieren, JM1
Van Deventer, HJ1
Stokkers, PC1
Van der Woude, JC1
Van Vuuren, AJ1
Benninga, MA1
Escher, JC1
Hommes, DW1
Duley, JA1
Marinaki, AM1
Arenas, M1
Murray, KF1
Tamori, A1
Shinzaki, M1
Kosaka, S1
Hayashi, T1
Iwai, S1
Enomoto, M1
Habu, D1
Kawada, N1
Hino, M1
Shiomi, S1
Nishiguchi, S1
Fargher, EA1
Newman, W1
Elliott, R1
Shaffer, JL1
Camilleri, M1
Saito, YA1
Ranganathan, P1
Haller, CA1
Markowitz, J1
Agarwal, K1
Czaja, AJ2
Jones, DE1
Donaldson, PT1
Sebbag, L1
Boucher, P1
Davelu, P1
Boissonnat, P1
Champsaur, G1
Ninet, J1
Dureau, G1
Obadia, JF1
Vallon, JJ1
Delaye, J1
Al-Khalidi, JA1
Cara Terribas, CJ1
González Guijarro, L1
Kuehn, F1
Klar, E1
Bliemeister, A1
Linnebacher, M1
Török, HP1
Glas, J1
Lohse, P1
Folwaczny, C1

Clinical Trials (3)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Effects of Abrocitinib Treatment of Moderate to Severe Atopic Dermatitis on Skin Barrier Function[NCT05140239]20 participants (Anticipated)Observational2022-09-01Recruiting
A Proof-of-Concept, Randomized, Double-Blind, Placebo-Controlled, Two-Arm, Parallel-Group, Nutritional Intervention Study to Examine the Clinical and Immunological Effects of a Probiotic Food Supplement Containing B. Infantis (EVC001) in Healthy Breastfed[NCT04662619]273 participants (Actual)Interventional2020-12-18Active, not recruiting
Effect of Aloe Vera in the Inflammation of Patients With Mild Ulcerative Colitis[NCT01783119]Early Phase 160 participants (Anticipated)Interventional2012-08-31Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

15 reviews available for azathioprine and Genetic Predisposition

ArticleYear
    Frontiers in immunology, 2021, Volume: 12

    Topics: Administration, Intravenous; Adrenal Cortex Hormones; AIRE Protein; Autoantibodies; Autoimmune Disea

2021
Atopic dermatitis.
    Nature reviews. Disease primers, 2018, 06-21, Volume: 4, Issue:1

    Topics: Administration, Topical; Adrenal Cortex Hormones; Azathioprine; Boron Compounds; Bridged Bicyclo Com

2018
Atopic dermatitis.
    Nature reviews. Disease primers, 2018, 06-21, Volume: 4, Issue:1

    Topics: Administration, Topical; Adrenal Cortex Hormones; Azathioprine; Boron Compounds; Bridged Bicyclo Com

2018
Atopic dermatitis.
    Nature reviews. Disease primers, 2018, 06-21, Volume: 4, Issue:1

    Topics: Administration, Topical; Adrenal Cortex Hormones; Azathioprine; Boron Compounds; Bridged Bicyclo Com

2018
Atopic dermatitis.
    Nature reviews. Disease primers, 2018, 06-21, Volume: 4, Issue:1

    Topics: Administration, Topical; Adrenal Cortex Hormones; Azathioprine; Boron Compounds; Bridged Bicyclo Com

2018
Thiopurine-induced pancreatitis in inflammatory bowel diseases.
    Expert review of gastroenterology & hepatology, 2015, Volume: 9, Issue:4

    Topics: Animals; Anti-Inflammatory Agents; Azathioprine; Colitis, Ulcerative; Crohn Disease; Gastrointestina

2015
Cutting edge issues in autoimmune hepatitis.
    Journal of autoimmunity, 2016, Volume: 75

    Topics: Azathioprine; Drug Therapy, Combination; Genetic Predisposition to Disease; Hepatitis, Autoimmune; H

2016
Autoimmune hepatitis.
    Best practice & research. Clinical gastroenterology, 2010, Volume: 24, Issue:5

    Topics: Animals; Azathioprine; Budesonide; Diagnosis, Differential; Drug Therapy, Combination; Genetic Predi

2010
Current relevance of pharmacogenetics in immunomodulation treatment for Crohn's disease.
    Journal of gastroenterology and hepatology, 2012, Volume: 27, Issue:10

    Topics: Antibodies, Monoclonal; Azathioprine; Biotransformation; Crohn Disease; Drug Hypersensitivity; Drug

2012
Prevention of autoimmune attack and disease progression in multiple sclerosis: current therapies and future prospects.
    Internal medicine journal, 2002, Volume: 32, Issue:11

    Topics: Adjuvants, Immunologic; Autoimmune Diseases; Azathioprine; B-Lymphocytes; Cyclophosphamide; Disease

2002
Pharmacogenetics and inflammatory bowel disease: progress and prospects.
    Inflammatory bowel diseases, 2004, Volume: 10, Issue:2

    Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Azathioprine; Drug Therapy, Combination; Female; Fo

2004
[Pharmacogenetics: Important aspects for dermatology].
    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2005, Volume: 56, Issue:1

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Dapsone; Dermatology; Drug Eruptions; Fluorou

2005
[Autoimmune liver diseases and their overlap syndromes].
    Praxis, 2006, Sep-06, Volume: 95, Issue:36

    Topics: Adult; Anti-Inflammatory Agents; Antibodies, Antinuclear; Autoantibodies; Autoimmune Diseases; Azath

2006
Pharmacogenomics in gastrointestinal disorders.
    Methods in molecular biology (Clifton, N.J.), 2008, Volume: 448

    Topics: Antineoplastic Agents; Azathioprine; Biotransformation; Colorectal Neoplasms; Gastrointestinal Agent

2008
Pharmacogenomics in rheumatoid arthritis.
    Methods in molecular biology (Clifton, N.J.), 2008, Volume: 448

    Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Biotransformation; Genetic Predisposition

2008
IBD in children: lessons for adults.
    Current gastroenterology reports, 2007, Volume: 9, Issue:6

    Topics: Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents; Antibodies, Antineutrophil Cytoplasmic; An

2007
Current concepts in the diagnosis, pathogenesis, and treatment of autoimmune hepatitis.
    Mayo Clinic proceedings, 2001, Volume: 76, Issue:12

    Topics: Age Distribution; Anti-Inflammatory Agents; Azathioprine; Causality; Drug Therapy, Combination; Euro

2001
Genetic variants and the risk of Crohn's disease: what does it mean for future disease management?
    Expert opinion on pharmacotherapy, 2006, Volume: 7, Issue:12

    Topics: Adaptor Proteins, Signal Transducing; Animals; Clinical Trials as Topic; Crohn Disease; Genetic Pred

2006

Trials

1 trial available for azathioprine and Genetic Predisposition

ArticleYear
A pragmatic randomized controlled trial of thiopurine methyltransferase genotyping prior to azathioprine treatment: the TARGET study.
    Pharmacogenomics, 2011, Volume: 12, Issue:6

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Drug-Related Side Effects and Adverse

2011

Other Studies

39 other studies available for azathioprine and Genetic Predisposition

ArticleYear
    Genetic testing and molecular biomarkers, 2019, Volume: 23, Issue:10

    Topics: Adolescent; Adult; Aged; Alleles; Asian People; Azathioprine; Biomarkers; Child; Female; Genetic Pre

2019
Rare Genotype of His/His in NUDT15 Codon 139 and Thiopurine-associated Adverse Events in a Case of Ulcerative Colitis.
    Internal medicine (Tokyo, Japan), 2020, Jul-01, Volume: 59, Issue:13

    Topics: Alopecia; Asian People; Azathioprine; Codon; Colitis, Ulcerative; Genetic Predisposition to Disease;

2020
Inflammatory bowel disease and inherited colorectal cancer: Is there a genetic link?
    Gastroenterologia y hepatologia, 2021, Volume: 44, Issue:2

    Topics: Adenocarcinoma; Adult; Age of Onset; Anti-Inflammatory Agents; Azathioprine; Breast Neoplasms; Colit

2021
Combined Detection of NUDT15 Variants Could Highly Predict Thiopurine-induced Leukopenia in Chinese Patients with Inflammatory Bowel Disease: A Multicenter Analysis.
    Inflammatory bowel diseases, 2017, Volume: 23, Issue:9

    Topics: Adolescent; Adult; Aged; Asian People; Azathioprine; Child; Child, Preschool; China; Cohort Studies;

2017
Extracellular matrix protein 1 gene rs3737240 single nucleotide polymorphism is associated with ulcerative colitis in Turkish patients.
    The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2017, Volume: 28, Issue:4

    Topics: Adult; Alleles; Asian People; Azathioprine; Case-Control Studies; Colitis, Ulcerative; Extracellular

2017
Rare gene variants in a patient with azathioprine-induced lethal myelosuppression.
    Annals of hematology, 2017, Volume: 96, Issue:12

    Topics: Azathioprine; Bone Marrow Diseases; Cholangitis, Sclerosing; Ethnicity; Genetic Predisposition to Di

2017
NUDT15 codon 139 is the best pharmacogenetic marker for predicting thiopurine-induced severe adverse events in Japanese patients with inflammatory bowel disease: a multicenter study.
    Journal of gastroenterology, 2018, Volume: 53, Issue:9

    Topics: Alopecia; Antibodies, Monoclonal; Azathioprine; Biomarkers, Pharmacological; Genetic Predisposition

2018
Long-term effect of NUDT15 R139C on hematologic indices in inflammatory bowel disease patients treated with thiopurine.
    Journal of gastroenterology and hepatology, 2019, Volume: 34, Issue:10

    Topics: Adult; Anti-Inflammatory Agents; Azathioprine; Colitis, Ulcerative; Crohn Disease; Erythrocyte Indic

2019
Primary sclerosing cholangitis, Crohn's disease and HLA-B27 in black South African women.
    Acta gastro-enterologica Belgica, 2012, Volume: 75, Issue:4

    Topics: Adult; Alkaline Phosphatase; Azathioprine; Back Pain; Black People; Cholagogues and Choleretics; Cho

2012
IL23R polymorphisms influence phenotype and response to therapy in patients with ulcerative colitis.
    European journal of gastroenterology & hepatology, 2014, Volume: 26, Issue:1

    Topics: Adrenal Cortex Hormones; Adult; Age Factors; Anti-Inflammatory Agents; Antibodies, Monoclonal; Azath

2014
Synergistic effect of interleukin-10-receptor variants in a case of early-onset ulcerative colitis.
    World journal of gastroenterology, 2013, Dec-14, Volume: 19, Issue:46

    Topics: Adenomatous Polyposis Coli; Age of Onset; Anti-Infective Agents; Azathioprine; beta Catenin; Biomark

2013
HLA-DQA1-HLA-DRB1 variants confer susceptibility to pancreatitis induced by thiopurine immunosuppressants.
    Nature genetics, 2014, Volume: 46, Issue:10

    Topics: Azathioprine; Gene Frequency; Genetic Predisposition to Disease; Genome-Wide Association Study; Geno

2014
NUDT15 R139C causes thiopurine-induced early severe hair loss and leukopenia in Japanese patients with IBD.
    The pharmacogenomics journal, 2016, Volume: 16, Issue:3

    Topics: Adult; Alopecia; Anti-Inflammatory Agents; Asian People; Azathioprine; Chi-Square Distribution; Coli

2016
The impact of glutathione S-transferase genotype and phenotype on the adverse drug reactions to azathioprine in patients with inflammatory bowel diseases.
    Journal of pharmacological sciences, 2015, Volume: 129, Issue:2

    Topics: Adolescent; Adult; Alleles; Analysis of Variance; Asian People; Azathioprine; Female; Genetic Predis

2015
TPMT and ITPA genetic variants in Lithuanian inflammatory bowel disease patients: Prevalence and azathioprine-related side effects.
    Advances in medical sciences, 2016, Volume: 61, Issue:1

    Topics: Adult; Azathioprine; Female; Gene Frequency; Genetic Predisposition to Disease; Genotyping Technique

2016
NUDT15 variant is the most common variant associated with thiopurine-induced early leukopenia and alopecia in Korean pediatric patients with Crohn's disease.
    European journal of gastroenterology & hepatology, 2016, Volume: 28, Issue:4

    Topics: Age Factors; Alopecia; Asian People; Azathioprine; Crohn Disease; Female; Gastrointestinal Agents; G

2016
Clinical epidemiology of ulcerative colitis in Mexico: a single hospital-based study in a 20-year period (1987-2006).
    Journal of clinical gastroenterology, 2009, Volume: 43, Issue:3

    Topics: Adult; Age of Onset; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Co

2009
Inflammatory bowel diseases: highlights from the United European Gastroenterology Week 2008.
    Expert opinion on therapeutic targets, 2009, Volume: 13, Issue:2

    Topics: Antibodies, Monoclonal; Azathioprine; Crohn Disease; Gastrointestinal Agents; Genetic Predisposition

2009
Eosinophilic myositis in calpainopathy: could immunosuppression of the eosinophilic myositis alter the early natural course of the dystrophic disease?
    Neuromuscular disorders : NMD, 2009, Volume: 19, Issue:4

    Topics: Azathioprine; Calpain; Child; Creatine Kinase; Disease Progression; Dose-Response Relationship, Drug

2009
Adverse reactions to azathioprine cannot be predicted by thiopurine S-methyltransferase genotype in Japanese patients with inflammatory bowel disease.
    Journal of gastroenterology and hepatology, 2009, Volume: 24, Issue:7

    Topics: Adult; Alopecia; Aminosalicylic Acids; Anti-Inflammatory Agents; Asian People; Azathioprine; Chemica

2009
Response to medical treatment in patients with Crohn's disease: the role of NOD2/CRAD15, disease phenotype, and age of diagnosis.
    Digestive diseases and sciences, 2010, Volume: 55, Issue:6

    Topics: Adolescent; Adult; Age Factors; Anti-Inflammatory Agents; Antibodies, Monoclonal; Azathioprine; Chi-

2010
Importance of thiopurine S-Methyltransferase gene polymorphisms for prediction of azathioprine toxicity.
    Neuro endocrinology letters, 2009, Volume: 30 Suppl 1

    Topics: Adult; Alleles; Azathioprine; Female; Genetic Predisposition to Disease; Genotype; Humans; Leukopeni

2009
Beyond these insights there are further applications and future challenges.
    QJM : monthly journal of the Association of Physicians, 2010, Volume: 103, Issue:4

    Topics: Azathioprine; Crohn Disease; Genetic Predisposition to Disease; Humans; Immunosuppressive Agents; Me

2010
Current concepts in the genetic diagnostics of rheumatoid arthritis.
    Expert review of molecular diagnostics, 2010, Volume: 10, Issue:5

    Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Genetic Predisposition to Disease; HLA-DR

2010
Common polymorphisms in the microsomal epoxide hydrolase and N-acetyltransferase 2 genes in association with inflammatory bowel disease in the Danish population.
    European journal of gastroenterology & hepatology, 2011, Volume: 23, Issue:3

    Topics: Adolescent; Adult; Arylamine N-Acetyltransferase; Azathioprine; Chronic Disease; Cohort Studies; Den

2011
Increased small intestinal permeability in ulcerative colitis: rather genetic than environmental and a risk factor for extensive disease?
    Inflammatory bowel diseases, 2012, Volume: 18, Issue:10

    Topics: Adult; Azathioprine; Case-Control Studies; Colitis, Ulcerative; Colon; Female; Genetic Predispositio

2012
ANCA-associated vasculitis with dual ANCA positivity in coexistence with mixed connective tissue disease.
    Modern rheumatology, 2013, Volume: 23, Issue:1

    Topics: Adult; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Antineutrophil Cytopl

2013
Autoimmune hepatitis: current knowledge.
    Clinics and research in hepatology and gastroenterology, 2012, Volume: 36, Issue:3

    Topics: Antibodies, Antinuclear; Autoantibodies; Autoantigens; Azathioprine; Child; Cyclosporine; Genetic Pr

2012
Gene polymorphisms involved in manifestation of leucopenia, digestive intolerance, and pancreatitis in azathioprine-treated patients.
    Digestive diseases and sciences, 2012, Volume: 57, Issue:9

    Topics: Azathioprine; Gastrointestinal Diseases; Gene Expression Regulation; Genetic Predisposition to Disea

2012
ITPA genotyping test does not improve detection of Crohn's disease patients at risk of azathioprine/6-mercaptopurine induced myelosuppression.
    Gut, 2005, Volume: 54, Issue:4

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Crohn Disease; Drug Therapy, Combination; Gen

2005
Pharmacogenetics of thiopurine therapy in paediatric IBD patients.
    Alimentary pharmacology & therapeutics, 2006, Apr-15, Volume: 23, Issue:8

    Topics: Adolescent; Azathioprine; Chi-Square Distribution; Child; Female; Gene Frequency; Genetic Predisposi

2006
Do ITPA and TPMT genotypes predict the development of side effects to AZA?
    Gut, 2006, Volume: 55, Issue:7

    Topics: Azathioprine; Genetic Predisposition to Disease; Humans; Immunosuppressive Agents; Inflammatory Bowe

2006
Autoimmune hepatitis: are we using the right therapy?
    Journal of pediatric gastroenterology and nutrition, 2007, Volume: 44, Issue:1

    Topics: Adolescent; Animals; Azathioprine; Child; Cyclosporine; Disease Models, Animal; Genetic Predispositi

2007
Thiopurine S-methyltransferase gene polymorphism in Japanese patients with autoimmune liver diseases.
    Liver international : official journal of the International Association for the Study of the Liver, 2007, Volume: 27, Issue:1

    Topics: Adult; Aged; Agranulocytosis; Asian People; Azathioprine; Bone Marrow; Female; Gastrointestinal Dise

2007
Current use of pharmacogenetic testing: a national survey of thiopurine methyltransferase testing prior to azathioprine prescription.
    Journal of clinical pharmacy and therapeutics, 2007, Volume: 32, Issue:2

    Topics: Attitude of Health Personnel; Azathioprine; Crohn Disease; Dermatology; Dose-Response Relationship,

2007
Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms and susceptibility to type 1 autoimmune hepatitis.
    Hepatology (Baltimore, Md.), 2000, Volume: 31, Issue:1

    Topics: Abatacept; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Antigens, CD; Antig

2000
Thiopurine S-methyltransferase gene polymorphism is predictive of azathioprine-induced myelosuppression in heart transplant recipients.
    Transplantation, 2000, Apr-15, Volume: 69, Issue:7

    Topics: Adult; Agranulocytosis; Azathioprine; Bone Marrow; Female; Forecasting; Genetic Predisposition to Di

2000
[Hypomethylation and multiple sclerosis, the susceptibility factor?].
    Neurologia (Barcelona, Spain), 2002, Volume: 17, Issue:3

    Topics: Autoimmune Diseases; Azathioprine; Genetic Predisposition to Disease; Humans; Immunosuppressive Agen

2002
Reactivity against microsatellite instability-induced frameshift mutations in patients with inflammatory bowel disease.
    World journal of gastroenterology, 2015, Jan-07, Volume: 21, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Autoantigens; Case-Control Studies; Female; Frameshift Mutation; Gen

2015